Zealand Pharma stock soars after selling insulin pump

The biotech firm is recovering losses on the stock exchange after a sales agreement with Mannkind Corporation over insulin pump V-Go was announced on Tuesday.


According to the Danish Financial Supervisory Authority, Zealand Pharma is one of the most speculative stocks listed on the Copenhagen stock exchange, a practice also known as shorting.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs